Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT04143906

Not yet recruiting

Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast Cancer

Metastatic Breast Cancer
NCT04020575

Recruiting

Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

Metastatic Breast Cancer
NCT03971019

Recruiting

Survival Benefits of Statins in Breast Cancer Patients (SBSBC)

Breast Cancer Female
NCT03824145

Recruiting

Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer (EDC)

Metastatic Breast Cancer
NCT03523078

Recruiting

Cosmetic Outcome, Patient-reported Outcomes, and Reconstruction-related Complications in Breast Cancer Women Treated With or Without Post-mastectomy Radiation Therapy

Breast Cancer Female
NCT03497702

Recruiting

Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer (NeoChAI)

Breast Cancer | Invasive Breast Cancer
NCT03424005

Recruiting

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer (Morpheus-panBC)

Metastatic Breast Cancer
NCT03182634

Recruiting

The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial (plasmaMATCH)

Advanced Breast Cancer
NCT03144648

Recruiting

PRECAMA: Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women (PRECAMA)

Breast Cancer Female
NCT02869607

Recruiting

Institut Paoli Calmettes Breast Cancer Database

Breast Cancer Diagnosis
NCT07014553

Active, not recruiting

Effect of Web-based Nursing Navigator Programme on Breast Cancer Screening Behaviors in Women at High Risk of Breast Cancer (WeT-HNP)

Breast Cancer Risk
NCT04370522

Terminated

Characterization of Innate Immune System in Patients With Luminal Advanced Breast Cancer (NIKOLE)

Metastatic Breast Cancer
NCT06503393

Completed

SENOVIE France - Therapeutic Mobility and Breast Cancer (SENOVIE)

Breast Cancer Female
NCT03850873

Completed

A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics

Advanced Breast Cancer
NCT04524000

Active, not recruiting

Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer

Advanced Breast Cancer
NCT06699875

Completed

Conventional Therapy vs. Telerehabilitation With TRAK in Patients Undergoing Axillary Lymph Node Removal

Breast Cancer Female
NCT04253561

Completed

Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients (IPATHER)

Metastatic Breast Cancer
NCT04085510

Active, not recruiting

Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania (TOCEM)

Neoplasms | Breast Cancer | Breast Neoplasms | Breast Cancer Female
NCT07421479

Active, not recruiting

Patient-Derived Breast Cancer Organoids for Therapeutic Extracellular Vesicle Isolation (PDO-Mercurial01) (PDO-Mercurial)

Invasive Breast Cancer
NCT02499146

Completed

Palbociclib Pharmacokinetics Study In Postmenopausal Chinese Women With ER (+), HER2 (-) Advanced Breast Cancer

Advanced Breast Cancer
NCT04639986

Active, not recruiting

Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)

Metastatic Breast Cancer
NCT01775085

Active, not recruiting

Group Interventions for Breast Cancer Survivors

Breast Cancer Survivor
NCT07386938

Active, not recruiting

A Study of the Efficacy, Safety and Pharmacokinetics of RPH-051 and Perjeta® in Combination With Trastuzumab and Docetaxel as the 1st Line Therapy in Patients With HER2-positive Breast Cancer

Metastatic Breast Cancer | Locally Advanced Breast Cancer
NCT04397185

Completed

Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer

Breast Cancer Female
NCT03212170

Completed

FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer

Invasive Breast Cancer
NCT01081288

Active, not recruiting

Extending the National Health Service (NHS) Breast Screening Age Range (AgeX)

Breast Cancer Mortality
NCT06884254

Withdrawn

Efficacy and Safety Study of EG1206A (EirGenix' Pertuzumab) Compared With EU-sourced Perjeta® (Pertuzumab) in Patients With HER2-positive Hormone Receptor Negative Early Breast Cancer. (EGC102)

Early Breast Cancer
NCT06449027

Active, not recruiting

Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.

Breast Cancer Subjects
NCT04937660

Completed

Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC (PRECIOUS)

Metastatic Breast Cancer
NCT04389216

Completed

Radiofrequency Ablation (RFA) in Breast Tumors (RFA)

Breast Cancer Female
NCT06604078

Completed

Breast Cancer AI Imaging Study

Breast Cancer | Breast Cancer Screening
NCT05063786

Active, not recruiting

Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET) (ALPHABET)

Advanced Breast Cancer
NCT05486182

Active, not recruiting

Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer (ESTROTIMP)

Metastatic Breast Cancer
NCT04497285

Active, not recruiting

Real World Study Using Comprehensive Genomic Data on the Next Treatment Decision Making in Metastatic Breast Cancer (HOPE)

Metastatic Breast Cancer
NCT06027541

Active, not recruiting

Young Patients With Early Breast Cancer

Breast Cancer Female
NCT06583655

Active, not recruiting

Precision Regional Node Irradiation for Sentinel Node-positive Breast Cancer

Breast Cancer Invasive
NCT04227327

Terminated

Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7) (HERMIONE-7)

Advanced Breast Cancer
NCT07056686

Enrolling by invitation

Early Detection of Breast Cancer Among Syrian Women

Breast Cancer Detection
NCT04082117

Active, not recruiting

Uptake of Genetic Counseling Among African American Women

Breast Cancer Risk
NCT02965755

Active, not recruiting

Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins (IMAGE-II)

Metastatic Breast Cancer
NCT05747209

Completed

EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Breast CA (EXERT-BC)

Breast Cancer Female
NCT04883398

Active, not recruiting

A Study of Attention and Memory Processes in Breast Cancer Survivors

Breast Cancer Survivors
NCT03437395

Active, not recruiting

Accelerated Partial Breast Irradiation Study (APBI)

Breast Cancer Female
NCT02299999

Active, not recruiting

SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer (SAFIR02_Breast)

Metastatic Breast Cancer
NCT01084876

Completed

Demonstrate Efficacy and Safety of Metastatic Breast Cancer (Compare)

Metastatic Breast Cancer
NCT03562832

Completed

Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP

Metastatic Breast Cancer
NCT03763604

Approved for marketing

Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer

Metastatic Breast Cancer
NCT02491983

Completed

Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast Cancer (PARSIFAL)

Metastatic Breast Cancer
NCT05760755

Completed

Stick Together - Pilot Intervention Study

Breast Cancer Female
NCT06612814

Active, not recruiting

PARP Inhibitor With CDK4/ 6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer

Breast Cancer Metastatic

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations